Twin Tree Management, LP Madrigal Pharmaceuticals, Inc. Call Options Transaction History

Twin Tree Management, LP

  • $50 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$212.22 - $292.96 $2.72 Million - $3.75 Million
-12,800 Reduced 14.24%
77,100 $16.4 Million
Q2 2024

Aug 13, 2024
BUY
$193.33 - $291.99 $8.91 Million - $13.5 Million
46,100 Added 105.25%
89,900 $25.2 Million
Q1 2024

May 09, 2024
BUY
$171.37 - $283.23 $7.51 Million - $12.4 Million
43,800 New
43,800 $11.7 Million

Others Institutions Holding MDGL

# of Institutions
297
Shares Held
22M
Call Options Held
819K
Put Options Held
640K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.34B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email